Swedish Orphan Biovitrum AB (publ) (BIOVF) News Today $28.30 0.00 (0.00%) As of 01/29/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Short Interest Down 7.8% in DecemberSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 1,377,300 shares, a decline of 7.8% from the December 15th total of 1,494,600 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 13,773.0 days.January 18, 2025 | marketbeat.comBerenberg Bank Sticks to Their Buy Rating for Swedish Orphan Biovitrum AB (0MTD)January 14, 2025 | markets.businessinsider.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Upgraded by Barclays to "Strong-Buy" RatingBarclays upgraded shares of Swedish Orphan Biovitrum AB (publ) to a "strong-buy" rating in a research note on Wednesday.January 9, 2025 | marketbeat.comNotice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)November 11, 2024 | prnewswire.comDavid Meek is proposed as new Chair of the Board of Directors of SobiNovember 5, 2024 | finance.yahoo.comKepler Capital Sticks to Their Hold Rating for Swedish Orphan Biovitrum AB (0MTD)October 29, 2024 | markets.businessinsider.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Short Interest UpdateSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 1,038,600 shares, a growth of 33.0% from the September 30th total of 780,900 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 10,386.0 days.October 27, 2024 | marketbeat.comSwedish Orphan Biovitrum Q3 Results Climb, Lifts FY24 Revenue View; Stock RisesOctober 24, 2024 | markets.businessinsider.comSwedish Orphan Biovitrum (OTC:BIOVF) Stock, Short Interest ReportOctober 15, 2024 | benzinga.comKepler Capital downgrades Swedish Orphan Biovitrum AB (0MTD) to a HoldSeptember 21, 2024 | markets.businessinsider.comShort Interest in Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Decreases By 9.6%Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 1,107,000 shares, a decline of 9.6% from the August 15th total of 1,224,400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 11,070.0 days.September 17, 2024 | marketbeat.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Hits New 12-Month High at $31.28Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Hits New 12-Month High at $31.28September 10, 2024 | marketbeat.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Reaches New 12-Month High at $30.55Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sets New 52-Week High at $30.55August 29, 2024 | marketbeat.comMirum Pharma gains amid report of approach from Swedish Orphan BiovitrumJuly 26, 2024 | msn.comSwedish Orphan Biovitrum AB (publ) (BIOVF)July 22, 2024 | uk.finance.yahoo.comSwedish Orphan Biovitrum AB (0MTD) Receives a Buy from RBC CapitalJuly 19, 2024 | markets.businessinsider.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Stock Price Down 1.7%Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Trading Down 1.7%July 3, 2024 | marketbeat.comSobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation SyndromeMay 24, 2024 | finance.yahoo.comSobi to present new myelofibrosis data at the ASCO 2024 Annual MeetingMay 24, 2024 | finance.yahoo.comSobi has completed SEK 3 billion senior bond issueMay 8, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB (publ) (SOBI.ST)May 6, 2024 | uk.finance.yahoo.comSwedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2024 Earnings Call TranscriptApril 27, 2024 | seekingalpha.comSobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia AApril 26, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB reports Q1 resultsApril 25, 2024 | msn.comSobi Q1 2024 report: Strong sales reflecting the strength of the portfolioApril 25, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB earnings: here's what to expectApril 24, 2024 | markets.businessinsider.comNotice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)April 4, 2024 | prnewswire.comSobi publishes Annual and sustainability report for 2023April 2, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sets New 52-Week High at $27.79Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Reaches New 12-Month High at $27.79March 12, 2024 | marketbeat.comSwedish Orphan Biovitrum AB (publ) (SWOBY)February 20, 2024 | au.finance.yahoo.comSobi publishes Q4 2023 report: Strong revenue performance and growth into 2024February 8, 2024 | finance.yahoo.comSwedish Orphan Biovitrum price target raised to SEK 385 at RBC CapitalFebruary 3, 2024 | realmoney.thestreet.comAll You Need to Know About Swedish Orphan Biovitrum (BIOVF) Rating Upgrade to Strong BuyFebruary 1, 2024 | finance.yahoo.comInvitation: Sobi's Q4 and FY 2023 reportJanuary 24, 2024 | finance.yahoo.comSobi's Chairman of the Board resigns due to health reasonsJanuary 5, 2024 | finance.yahoo.comChange in number of shares and votes in Swedish Orphan Biovitrum AB (publ)November 30, 2023 | finance.yahoo.comSwedish Orphan Biovitrum AB BIOVFNovember 23, 2023 | morningstar.comSobi has completed the issuances of series C sharesNovember 1, 2023 | finance.yahoo.comSwedish Orphan Biovitrum AB Non-GAAP EPS of SEK0.54, revenue of SEK5.17BOctober 30, 2023 | msn.comSwedish Orphan Biovitrum (BIOVF) Q3 Earnings Miss EstimatesOctober 30, 2023 | finance.yahoo.comSobi publishes Q3 2023 report: Strong revenue and solid performanceOctober 30, 2023 | finance.yahoo.comReminder: Invitation: Sobi's Q3 2023 reportOctober 27, 2023 | finance.yahoo.comInvitation: Sobi's Q3 2023 reportOctober 18, 2023 | finance.yahoo.comReminder: Sobi KOL investor event: Advancing the standard of care in haemophiliaSeptember 15, 2023 | finance.yahoo.comSobi KOL investor event: Advancing the standard of care in haemophiliaSeptember 8, 2023 | finance.yahoo.comIs Swedish Orphan Biovitrum (BIOVF) Stock Undervalued Right Now?August 29, 2023 | finance.yahoo.comSobi resolves on a rights issue of approximately SEK 6,024 millionAugust 22, 2023 | finance.yahoo.comBulletin from Swedish Orphan Biovitrum (Sobi)'s Extraordinary General Meeting (EGM)August 15, 2023 | finance.yahoo.comNotice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)July 19, 2023 | tmcnet.comSwedish Orphan Biovitrum (BIOVF) Beats Q2 Earnings and Revenue EstimatesJuly 18, 2023 | finance.yahoo.com Get Swedish Orphan Biovitrum AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOVF and its competitors with MarketBeat's FREE daily newsletter. Email Address BIOVF Media Mentions By Week BIOVF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOVF News Sentiment▼1.000.74▲Average Medical News Sentiment BIOVF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOVF Articles This Week▼10▲BIOVF Articles Average Week Get Swedish Orphan Biovitrum AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GE HealthCare Technologies News Today argenx News Today UCB News Today IQVIA News Today ResMed News Today Veeva Systems News Today IDEXX Laboratories News Today Humana News Today DexCom News Today Alnylam Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BIOVF) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Swedish Orphan Biovitrum AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Swedish Orphan Biovitrum AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
